Announcements

Date	Title
05 Apr 24, 14:00	Psych Capital PLC - Board Resignation, Role Change and Option Grant	View
01 Mar 24, 14:10	Psych Capital PLC - Total Voting Rights	View
02 Feb 24, 07:00	Psych Capital PLC - Operational Update, Share Options and Share Issue	View
30 Jan 24, 07:00	Psych Capital PLC - Interim Results to 31 October 2023	View
01 Dec 23, 08:50	Psych Capital PLC - Holding(s) in Company	View
30 Nov 23, 16:14	Psych Capital PLC - Total Voting Rights	View
07 Nov 23, 07:00	Psych Capital PLC - Board Changes and Shortwave Pharma Completion	View
31 Oct 23, 12:04	Psych Capital PLC - AUDITED RESULTS FOR THE YEAR ENDED 30 APRIL 2023	View
07 Jul 23, 08:00	Psych Capital PLC - PSYCH Symposium 2023	View
22 Jun 23, 07:00	Psych Capital PLC - PSYCH Symposium 2023: 6th July 2023	View
19 Jun 23, 07:00	Psych Capital PLC - Acquisition of Short Wave Pharma for £3.5m	View
25 Apr 23, 07:00	Psych Capital PLC - PSYCH SYMPOSIUM 6th JULY, LONDON	View
31 Jan 23, 15:03	Psych Capital PLC - Interim Results to 31 October 2022	View
28 Nov 22, 14:43	Psych Capital PLC - Result of AGM	View
04 Nov 22, 15:48	Psych Capital PLC - Notice of Annual General Meeting	View
31 Oct 22, 16:04	Psych Capital PLC - AUDITED RESULTS TO 30 APRIL 2022	View
20 Oct 22, 07:00	Psych Capital PLC - Drug Reform Group Representative Appointment	View
16 Aug 22, 07:00	Psych Capital PLC - Awakn Expands Commercial Operations Into The U.S	View
21 Jul 22, 12:47	Psych Capital PLC - Awakn Phase III Trial receives CA$2.5m funding	View
16 Jun 22, 07:00	Psych Capital PLC - Awakn Reports Results for 1Q22	View